| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |